Peru's Auna Q3 revenue rises on growth across markets
Overview
Peru-based healthcare platform's Q3 revenue rose 10% FX-neutral, driven by growth in all markets
Q3 adjusted EBITDA declined 5% FX-neutral, with margin at 17.5%
Profitability pressured by higher costs in Colombia and Peru, partly offset by Mexico recovery
Outlook
Auna reaffirms full-year 2026 revenue guidance for FX-neutral growth of 10% to 14%
Company expects full-year 2026 Adjusted EBITDA to be broadly stable or slightly down year-over-year
Auna maintains capital expenditures guidance at about 4% of revenues for 2026
Result Drivers
MEXICO RECOVERY - Segment adjusted EBITDA in Mexico grew year-over-year, driven by higher surgical and oncology volumes and improved capacity utilization at the Monterrey Healthcare network, partly offset by weaker results at Auna Seguros
COLOMBIA PROFITABILITY PRESSURE - Adjusted EBITDA in Colombia declined due to extraordinary adverse medical costs under a specific oncology risk-sharing contract, regulatory price caps on high-cost oncology medications, and higher personnel costs
PERU COST IMPACTS - Profitability in Peru was affected by penalties from reconciliation of prior years’ receivables and higher pharmacy and clinical payroll costs associated with increased patient volumes
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Adjusted EBITDA Margin | 17.50% |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The stock recently traded at 4 times the next 12-month earnings vs. a P/E of 4 three months ago
Reuters Recommended Reads
Nov 17 - France's Alstom posts first-half loss on setbacks in German rail project
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)